|
|
Subscribe
to our newsletter:
| |
|
|
|
|
Search results for: liver disease
1 - 5 of 68 <<previous | next>>
Drugs results:
|
Zolpidem is in a class of drugs called sedative/ hypnotics or sleep medications. Zolpidem affects chemicals in your brain that may become unbalanced and cause insomnia.
Zolpidem induces sleep and causes relaxation. It is used to treat sleep disorders suc more...
|
|
Sibutramine is an anti-obesity agent. It affects chemicals in the body that are related to
weight maintenance.
Indication: for treatment of obesity as short-term supplement to diet and exercise
Special precautions: Do not take sibutramine more...
|
|
Bupropion is an antidepressant medication. This medicine is used to treat major depressive disorder and seasonal affective disorder.
One brand of bupropion, the Zyban is used to help reduce the cravings and other withdrawal effects of those people who ar more...
|
|
Atorvastatin belong to a class of drug known as HMG CoA reductase inhibitor. This drug works by blocking the production of cholesterol (a type of fat) in the body.
Indications: to reduce the amounts of low density lipoprotein or LDL (bad) cholesterol, more...
|
|
Esomeprazole belong to a class of drug known as proton pump inhibitor that works by decreasing the amount of hydrochloric acid produced by the parietal cells in the stomach.
Indications: treatment of gastroesophageal reflux disease (GERD) and erosive more...
|
Diseases results:Insomnia
Obesity
Stop smoking
Reduce cholesterol
Flatulence
Migraine headaches
Itching
Supplement
Peritonitis
PruritusArticles results:
| FDA Revises Label Warnings On The Antibiotic Ketek |
The US Food and Drug Administration (FDA) has revised the label warnings on the antibiotic Ketek, to improve safe use by patients. Ketek is the brand name of Telithromycin and is manufactured by Sanofi-Aventis.The FDA has removed approval of the drug for treatment of acute bacterial infections associated with sinusitis and chronic bronchitis.
|
| FDA Announces Label And Indication Changes For The Antibiotic Ketek |
The Food and Drug Administration (FDA) today announced revisions to the labeling for the antibiotic Ketek (telithromycin) designed to improve the safe use of Ketek by patients. The changes include the removal of two of the three previously approved indications - acute bacterial sinusitis and acute bacterial exacerbations of chronic bronchitis - from the drug's label.
|
| FDA Requests Boxed Warning For Contrast Agents Used To Improve MRI Images |
The U.S. Food and Drug Administration (FDA) has asked manufacturers to include a new boxed warning on the product labeling of all gadolinium-based contrast agents which are used to enhance the quality of magnetic resonance imaging (MRI). The requested warning would state that patients with severe kidney insufficiency who receive gadolinium-based agents are at risk for developing a debilitating, and a potentially fatal disease known as nephrogenic systemic fibrosis (NSF).
|
1 - 5 of 68 <<previous | next>>
|
|
|
